AFL:NYE-Aflac Incorporated (USD)

COMMON STOCK | Insurance - Life |

Last Closing

USD 110.09

Change

+0.09 (+0.08)%

Market Cap

USD 61.65B

Volume

1.43M

Analyst Target

USD 41.11
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia. Address: 1932 Wynnton Road, Columbus, GA, United States, 31999

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Insurance - Life

Symbol Name Price(Change) Market Cap
MET-PA MetLife Inc Preferred Stock Se..

+0.17 (+0.69%)

USD 47.76B
PRU Prudential Financial Inc

+1.37 (+1.09%)

USD 44.68B
MET-PE MetLife Inc Preferred Stock Se..

+0.03 (+0.12%)

USD 44.02B
PUK Prudential Public Limited Comp..

-0.18 (-1.07%)

USD 23.52B
PRI Primerica Inc

+1.83 (+0.66%)

USD 9.37B
JXN Jackson Financial Inc

+0.80 (+0.78%)

USD 7.44B
FG F&G Annuities & Life Inc.

-0.15 (-0.36%)

USD 5.38B
ANG-PB American National Group Inc

+0.02 (+0.08%)

N/A
ANG-PA American National Group Inc.

+0.11 (+0.44%)

N/A
MET-PF MetLife Inc Preferred Stock Se..

-0.02 (-0.09%)

N/A

ETFs Containing AFL

FLI:CA CI U.S. & Canada Lifeco C.. 10.18 % 0.92 %

+0.06 (+0%)

CAD 0.09B
CWS AdvisorShares Focused Equ.. 4.76 % 0.68 %

-0.24 (0%)

USD 0.18B
DIVS SmartETFs Dividend Builde.. 3.28 % 0.00 %

-0.07 (0%)

USD 0.03B
VSMV VictoryShares US Multi-Fa.. 2.99 % 0.35 %

-0.06 (0%)

USD 0.13B
CCOR Core Alternative ETF 2.90 % 1.23 %

-0.21 (0%)

USD 0.12B
NSGE:CA NBI Sustainable Global Eq.. 2.54 % 0.00 %

N/A

CAD 0.53B
LYLD 2.36 % 0.00 %

N/A

N/A
JSTC Tidal ETF Trust - Adasina.. 2.35 % 0.00 %

+0.02 (+0%)

USD 0.21B
FCSG:LSE FIRST TRUST GLOBAL FUNDS .. 2.33 % 0.00 %

-7.00 (0%)

USD 0.03B
CESG:LSE FIRST TRUST GLOBAL FUNDS .. 2.07 % 0.00 %

-0.08 (0%)

N/A
QDIV Global X S&P 500® Qualit.. 2.01 % 0.00 %

+0.08 (+0%)

USD 0.03B
KNG 1.71 % 0.00 %

N/A

N/A
TPHE Timothy Plan - Timothy Pl.. 1.45 % 0.00 %

+0.04 (+0%)

USD 0.07B
IMCV iShares Morningstar Mid-C.. 1.03 % 0.00 %

+0.09 (+0%)

USD 0.65B
IWS iShares Russell Mid-Cap V.. 0.70 % 0.24 %

+0.19 (+0%)

USD 13.47B
IWR iShares Russell Mid-Cap E.. 0.53 % 0.19 %

+0.02 (+0%)

USD 36.97B
CORP PIMCO Investment Grade Co.. 0.00 % 0.20 %

-0.07 (0%)

USD 1.27B
FHF:CA 0.00 % 0.77 %

N/A

N/A
FTCS First Trust Capital Stren.. 0.00 % 0.60 %

+0.21 (+0%)

USD 9.16B
FUM:CA 0.00 % 0.80 %

N/A

N/A
IAK iShares U.S. Insurance ET.. 0.00 % 0.43 %

+0.52 (+0%)

N/A
JKI 0.00 % 0.30 %

N/A

N/A
PHE.B:CA 0.00 % 0.97 %

N/A

N/A
QSY 0.00 % 0.38 %

N/A

N/A
CLRG 0.00 % 0.25 %

N/A

N/A
BDIV:CA Brompton Global Dividend .. 0.00 % 0.96 %

-0.12 (0%)

CAD 0.09B
BFIN:CA Brompton North American F.. 0.00 % 0.96 %

+0.04 (+0%)

CAD 0.06B
SYLD 0.00 % 0.59 %

N/A

N/A
DBX4:F Xtrackers - MSCI EM Europ.. 0.00 % 0.00 %

N/A

N/A
VLIQ:XETRA 0.00 % 0.00 %

N/A

N/A
VDLQ:LSE 0.00 % 0.00 %

N/A

N/A
ADIV SmartETFs Asia Pacific Di.. 0.00 % 0.00 %

-0.16 (0%)

USD 4.54M
FTGS:XETRA FIRST TRUST GLOBAL FUNDS .. 0.00 % 0.00 %

-0.25 (0%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Insurance - Life) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -66.64% 6% D- 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -66.64% 11% F 11% F
Trailing 12 Months  
Capital Gain -65.18% 6% D- 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -65.18% 11% F 10% F
Trailing 5 Years  
Capital Gain -48.66% 13% F 15% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -48.66% 20% F 23% F
Average Annual (5 Year Horizon)  
Capital Gain 20.56% 78% C+ 82% B
Dividend Return 23.24% 78% C+ 82% B
Total Return 2.68% 38% F 58% F
Risk Return Profile  
Volatility (Standard Deviation) 24.35% 67% D+ 44% F
Risk Adjusted Return 95.47% 94% A 96% N/A
Market Capitalization 61.65B 100% F 96% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector